Your browser doesn't support javascript.
loading
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study.
Noe, Megan H; Wan, Marilyn T; Shin, Daniel B; Armstrong, April W; Duffin, Kristina Callis; Chiesa Fuxench, Zelma C; Kalb, Robert E; Menter, Alan; Simpson, Eric L; Takeshita, Junko; Tyring, Stephen K; Van Voorhees, Abby S; Mehta, Nehal N; Gelfand, Joel M.
Afiliação
  • Noe MH; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: Megan.Noe@pennmedicine.upenn.edu.
  • Wan MT; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Shin DB; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Armstrong AW; Department of Dermatology, Keck School of Medicine of University of Southern California, Los Angeles, California.
  • Duffin KC; Department of Dermatology, University of Utah, Salt Lake City, Utah.
  • Chiesa Fuxench ZC; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Kalb RE; Department of Dermatology, University of Buffalo, Williamsville, New York.
  • Menter A; Department of Dermatology, Baylor University Medical Center, Dallas, Texas.
  • Simpson EL; Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
  • Takeshita J; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Tyring SK; Department of Dermatology, University of Texas, McGovern Medical School, Dallas, Texas.
  • Van Voorhees AS; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia.
  • Mehta NN; Cardiopulmonary Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
  • Gelfand JM; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: Joel.Gelfand@pennmedicine.upenn.e
J Am Acad Dermatol ; 81(4): 923-930, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31163241
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Qualidade de Vida / Terapia Ultravioleta / Adalimumab / Anti-Inflamatórios Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Qualidade de Vida / Terapia Ultravioleta / Adalimumab / Anti-Inflamatórios Idioma: En Ano de publicação: 2019 Tipo de documento: Article